Always easiest to say nothing when there's nothing to say. Investor presentation dated 16/09/20 "GeneType Breast Cancer and Colorectal tests are in market with anticipatedrelease of Cardiovascular and T2D tests in Q3 CY20" Clearly cardiovascular and Type 2 diabetes tests are another missed timeline.
- Forums
- ASX - By Stock
- GTG
- The vast majority of the world(90%) remains at risk..
The vast majority of the world(90%) remains at risk.., page-20
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.270M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 5.0¢ | $6.24K | 123.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 8955 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.049 |
1 | 208333 | 0.048 |
1 | 80 | 0.047 |
1 | 22222 | 0.045 |
1 | 227272 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 8955 | 1 |
0.051 | 9815 | 1 |
0.052 | 19249 | 1 |
0.053 | 25000 | 1 |
0.058 | 10000 | 1 |
Last trade - 15.36pm 19/07/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |